NO983464D0 - Buffer systems for stabilizing pharmaceutical preparations - Google Patents

Buffer systems for stabilizing pharmaceutical preparations

Info

Publication number
NO983464D0
NO983464D0 NO983464A NO983464A NO983464D0 NO 983464 D0 NO983464 D0 NO 983464D0 NO 983464 A NO983464 A NO 983464A NO 983464 A NO983464 A NO 983464A NO 983464 D0 NO983464 D0 NO 983464D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
buffer systems
stabilizing pharmaceutical
stabilizing
buffer
Prior art date
Application number
NO983464A
Other languages
Norwegian (no)
Other versions
NO983464L (en
Inventor
Andreas Sachse
Ralf-Siegbert Hauck
Georg Roessling
Detlef Goeritz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO983464L publication Critical patent/NO983464L/en
Publication of NO983464D0 publication Critical patent/NO983464D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
NO983464A 1996-01-29 1998-07-28 Buffer systems for stabilizing pharmaceutical preparations NO983464D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604230 1996-01-29
PCT/DE1996/002488 WO1997028104A2 (en) 1996-01-29 1996-12-20 Buffer systems for use in stabilizing pharmaceutical preparations

Publications (2)

Publication Number Publication Date
NO983464L NO983464L (en) 1998-07-28
NO983464D0 true NO983464D0 (en) 1998-07-28

Family

ID=7784639

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983464A NO983464D0 (en) 1996-01-29 1998-07-28 Buffer systems for stabilizing pharmaceutical preparations

Country Status (7)

Country Link
EP (1) EP0877628A2 (en)
JP (1) JP2000504334A (en)
AU (1) AU1870497A (en)
CA (1) CA2244213A1 (en)
DE (1) DE19648650C2 (en)
NO (1) NO983464D0 (en)
WO (1) WO1997028104A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance
JP2005170928A (en) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc Lyposome-containing x ray-imaging agent and method for producing the same
JP2005170923A (en) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc Lyposome-containing x ray-imaging agent and method for producing the same
JP2005220034A (en) * 2004-02-03 2005-08-18 Konica Minolta Medical & Graphic Inc Method for producing contrast medium for roentgenologic examination
JP4654590B2 (en) * 2004-03-31 2011-03-23 コニカミノルタエムジー株式会社 Contrast composition for X-ray CT and method for producing the same
WO2006009022A1 (en) * 2004-07-21 2006-01-26 Konica Minolta Medical & Graphic, Inc. Liposome-containing x-ray radiopaque dye and process for producing the same
JP5947784B2 (en) * 2010-03-23 2016-07-06 ジーイー・ヘルスケア・アクスイェ・セルスカプ Method for producing stabilized X-ray diagnostic composition
EP2883542B1 (en) 2012-08-10 2019-05-01 Taiho Pharmaceutical Co., Ltd. Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
US9987314B2 (en) 2013-10-25 2018-06-05 Psioxus Therapeutics Limited Oncolytic adenoviruses armed with heterologous genes
JP6867639B2 (en) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 Combined nonionic iodine contrast agent
GB201801614D0 (en) * 2018-01-31 2018-03-14 Psioxus Therapeutics Ltd Formulation
EP4011369A1 (en) 2020-12-14 2022-06-15 G.L. Pharma GmbH Aqueous pharmaceutical composition comprising tapentadol tartrate
JP7353453B1 (en) 2022-10-31 2023-09-29 キユーピー株式会社 Emulsion and its manufacturing method
JP7372429B1 (en) 2022-10-31 2023-10-31 キユーピー株式会社 Emulsion and its manufacturing method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR222337A1 (en) * 1978-07-04 1981-05-15 Nyegaard & Co As PROCEDURE FOR PREPARING A PHYSIOLOGICALLY ACCEPTABLE INJECTABLE STERILE SOLUTION FROM AN X-RAY CONTRAST AGENT
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4121568C2 (en) * 1991-04-22 1997-07-03 Schering Ag Method and device for producing a contrast medium from a concentrate
IT1256248B (en) * 1992-12-24 1995-11-29 Bracco Spa WATER INJECTABLE FORMULATIONS FOR RADIODIAGNOSTICS INCLUDING MIXTURES OF IODURATED AROMATIC COMPOUNDS USEFUL AS X-RAY MATTING AGENTS

Also Published As

Publication number Publication date
JP2000504334A (en) 2000-04-11
DE19648650C2 (en) 1998-07-02
AU1870497A (en) 1997-08-22
CA2244213A1 (en) 1997-08-07
NO983464L (en) 1998-07-28
DE19648650A1 (en) 1997-08-07
WO1997028104A8 (en) 1997-12-18
WO1997028104A3 (en) 1997-09-12
EP0877628A2 (en) 1998-11-18
WO1997028104A2 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
NO974618D0 (en) Pharmaceutical preparations for intranasal administration
NO986023D0 (en) Water-based pharmaceutical preparations
IS5953A (en) Pharmaceutical preparations from microplated eplerenones
NO945054L (en) Implementation Independent Interface Specification System
NO954146D0 (en) Coated pharmaceutical preparations
DE69711045T2 (en) VITAMIN C DELIVERY SYSTEM
BR9611367A (en) Stable lyophilized pharmaceutical formulation
DE69625368T2 (en) SWEAT-RESISTANT DEODORATING PREPARATIONS
DK0981375T3 (en) Pharmaceutical preparations containing plasma protein
NO20016277D0 (en) Systems and methods for aerolizing pharmaceutical formulations
DE59703144D1 (en) ACTIVE SUSPENSION SYSTEM
DE59701787D1 (en) MEDICINE DOSING SYSTEM
DK1124582T3 (en) Preservation system for topically deliverable pharmaceutical preparations
FI961437A0 (en) Active substance delivery system
NO983464D0 (en) Buffer systems for stabilizing pharmaceutical preparations
NO982874D0 (en) Pharmaceutical preparations with vitamin D analogues
DE69719151T2 (en) processing system
DE59707298D1 (en) DESODORING PREPARATIONS
EE9900260A (en) Pharmaceutical compositions for freeze-drying
ID16781A (en) PHARMACEUTICAL FORMULATIONS
DK0925273T3 (en) Pharmaceutical preparations containing 4-oxo-butanoic acids
DK1041966T3 (en) Pharmaceutical preparations comprising zafirlukast
DE69714166T2 (en) amplifier system
EE03511B1 (en) Prolonged release pharmaceutical preparations containing misolastin
NO951350D0 (en) Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application